• 1
    Wollert KC, Drexler H. Clinical applications of stem cells for the heart. Circul Res 2005; 96:151163.
  • 2
    Beeres SLMA, Bengel FM, Bartunek J, Atsma DE, Hill JM, Vanderheyden M, Penicka M, Schalij MJ, Wijns W, Bax JJ. Role of imaging in cardiac stem cell therapy. JACC 2007; 49(11):11371148.
  • 3
    Blackwood KJ, Sabondjian E, Goldhawk DE, Kovacs MS, Wisenberg G, Merrifield P, Prato FS, DeMoor JM, Stodilka RZ. Progress in Stem Cell Applications. Nova: New York, 2008; chapter V.
  • 4
    Hinds KA, Hill JM, Shapiro EM, Laukkanen MO, Silva AC, Combs CA, Varney TR, Balaban RS, Koretsky AP, Dunbar CE. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 2003; 102:867872.
  • 5
    Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, Hare JM, Bulte JWM. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003; 107:22902293.
  • 6
    Chen IY, Greve JM, Gheysens O, Willmann JK, Rodriguez-Porcel M, Chu P, Sheikh AY, Faranesh AZ, Paulmurugan R, Yang PC, Wu JC, Gambhir SS. Comparison of optical bioluminescence reporter gene and superparamagnetic iron oxide MR contrast agent as cell markers for noninvasive imaging of cardiac cell transplantation. Mol Imag Biol 2009 May–Jun; 11(3):17887.
  • 7
    Jacquier A, Higgins CB, Saeed M. MR imaging in assessing cardiovascular interventions and myocardial injury. Contrast Media Mol Imag 2007; 2:115.
  • 8
    Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. New Engl J Med 2000 Nov; 343(20):14451453.
  • 9
    Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, Ganser A, Knapp WH, Drexler H. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005; 111:21982202.
  • 10
    Huang J, Lee CCI, Sutcliffe JL, Cherry SR, Tarantal AF. Radiolabeling rhesus monkey CD34+ hematopoietic and mesenchymal stem cells with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for microPET imaging. Mol Imag 2008; 7(1):111.
  • 11
    Kraitchman DL, Tatsumi M, Gilson WD, Ishimori T, Kedziorek D, Walczak P, Segars P, Chen HH, Fritzges D, Izbudak I, Young RG, Marcelino M, Pittenger MF, Solaiyappan M, Boston RC, Tsui BMW, Wahl RL, Bulte JWM. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 2005; 112:14511461.
  • 12
    Blackwood KJ, Lewden B, Wells RG, Sykes J, Stodilka RZ, Wisenberg G, Prato FS. In vivo SPECT quantification of transplanted cell survival following engraftment using 111In-tropolone in infarcted canine myocardium. J Nucl Med 2009; 50(6):927935.
  • 13
    Ho KT, Panknin C. CT myocardial perfusion imaging of myocardial blood flow reserve before and after coronary artery stenting. J Cardiovasc Comput Tomogr 2012; 5:125126.
  • 14
    Mahnken AH, Klotz E, Pietsch H, Schmidt B, Allmendinger T, Haberland U, Kalender WA, Flohr T. Quantitative whole heart stress perfusion CT imaging as non-invasive assessment of hemodynamics in coronary artery stenosis: preliminary animal experience. Invest Radiol 2010; 45:298305.
  • 15
    He H, Shirota T, Yasui H, Matsuda T. Canine endothelial progenitor cell-lined hybrid vascular graft with nonthrombogenic potential. J Thorac Cardiovasc Surg 2002; 126(2):455464.
  • 16
    Mitchell AJ, Sabondjian E, Sykes J, Deans L, Zhu W, Lu X, Feng Q, Prato FS, Wisenberg G. Comparison of initial cell retention and clearance kinetics after subendocardial or subepicardial injections of endothelial progenitor cells in a canine myocardial infarction model. J Nucl Med 2010; 51:413417.
  • 17
    Utsunomiya D, Nakaura T, Honda T, Shiraishi S, Tomiguchi S, Kawanaka K, Morishita S, Awai K, Ogawa H, Yamashita Y. Object-specific attenuation correction at SPECT/CT in thorax: optimization of respiratory protocol for image registration. Radiology 2005; 237:662669.
  • 18
    Holz A, Lautamaki R, Sasano T, Merrill J, Nekolla SG, Lardo AC, Bengel FM. Expanding the versatility of cardiac PET/CT: feasibility of delayed contrast enhancement CT for infarct detection in a porcine model. J Nucl Med 2009; 50(2):259265.
  • 19
    Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 2003 Jul; 5(3):505514.
  • 20
    Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002 Jan; 105(4):539542.
  • 21
    Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subset of projection data. IEEE Trans Med Imag 1994; 13(4):601609.
  • 22
    Jin Y, Kong H, Stodilka RZ, Wells RG, Zabel P, Merrifield PA, Sykes J, Prato FS. Determining the minimum number of detectable cardiac-transplanted 111In-tropolone-labelled bone-marrow-derived mesenchymal stem cells by SPECT. Phys Med Biol 2005; 50(19):44454455.
  • 23
    Wisenberg G, Lekx K, Zabel P, Kong H, Mann R, Zeman PR, Datta S, Culshaw CN, Merrifield P, Bureau Y, Wells RG, Sykes J, Prato FS. Cell tracking and therapy evaluation of bone marrow monocytes and stromal cells using SPECT and CMR in a canine model of myocardial infarction. J Cardiovasc Magn Reson 2009 Apr 27; 11(1):11.
  • 24
    Fieno DS, Hillenbrand HB, Rehwald WG. Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size. J Am Coll Cardiol 2004 Jun 2; 43(11):212431.
  • 25
    Rose A. Vision: Human and Electronic. Plenum: New York, 1973; 123.
  • 26
    Mahnken AH, Bruners P, Katoh M, Wildberger JE, Gunther RW, Buecker A. Dynamic multi-section CT imaging in acute myocardial infarction: preliminary animal experience. Eur Radiol 2006; 16(3):746752.
  • 27
    Rochitte CE, Lima JA, Bluemke DA, Reeder SB, McVeigh ER, Furuta T, Becker LC, Melin JA. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998; 98(10):10061014.
  • 28
    Nieman K, Shapiro MD, Ferencik M, Nomura CH, Abbara S, Hoffmann U, Gold HK, Jang IK, Brady TJ, Cury RC. Reperfused myocardial infarction: contrast-enhanced 64-slice CT in comparison to MR imaging. Radiology 2008; 247(1):4956.
  • 29
    Diesbourg LD, Prato FS, Wisenberg G, Drost DJ, Marshall TP, Carroll SE, O'Neill B. Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn Reson Med 1992; 23(2):239253.
  • 30
    Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, Blumenthal RS, Lima JAC. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998; 97:765772.
  • 31
    Brenner W, Aicher A, Eckey T, Massoudi A, Zuhayra M, Koehl U, Heeschen C, Kampen WU, Zeiher AM, Dimmeler S, Henze E. 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. J Nucl Med 2004; 45(3):512518.
  • 32
    Rahmim A, Zaidi H. PET vs SPECT: strength, limitations, and challenges. Nucl Med Commun 2008; 29(3):193207.
  • 33
    Blocklet D, Toungouz M, Berkenboom G, Lambermont M, Unger P, Preumont N, Stoupel E, Egrise D, Degaute JP, Goldman M, Goldman S. Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection. Stem Cells 2006; 24:333336.
  • 34
    Bettinardi V, Mancosu P, Danna M, Giovacchini G, Landoni C, Picchio M, Gilardi MC, Savi A, Castiglioni I, Lecchi M, Fazio F. Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: a Discovery-STE phantom and patient study. Q J Nucl Med Mol Imag 2007 Sep; 51(3):214223.
  • 35
    Williams HA, Robinson S, Julyan P, Zweit J, Hastings D. A comparison of PET imaging characteristics of various copper radioisotopes. Eur J Nucl Med Mol Imag 2005; 32(12):14731480.
  • 36
    Terrovitis J, Kwok KF, Lautamäki R, Engles JM, Barth AS, Kizana E, Miake J, Leppo MK, Fox J, Seidel J, Pomper M, Wahl RL, Tsui B, Bengel F, Marbán E, Abraham MR. Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. J Am Coll Cardiol 2008; 52(20):16521660.
  • 37
    Surti S, Scheuermann R, Karp JS. Correction technique for cascade gammas in I-124 imaging on a fully-3D, time-of-flight PET scanner. IEEE Trand Nucl Sci 2009; 56(3):653660.
  • 38
    Terrovitis JV, Smith RR, Marban E. Assessment and optimization of cell engraftment after transplantation into the heart. Circul Res 2010; 106:479494.
  • 39
    Stodilka RZ, Blackwood KJ, Prato FS. Tracking transplanted cells using dual-radionuclide SPECT. Phys Med Biol 2006; 51:26192632.
  • 40
    Morin RL, Gerber TC, McCollough CH. Radiation dose in computed tomography of the heart. Circulation 2003; 107:917922.
  • 41
    Monson RR, Cleaver JE, Abrams HL, Bingham E, Buffler PA, Cardis E, Cox R, Davis S, Hutchinson F, Dewey WC, Gilbert ES, Kellerer AM, Krewski D, Lindahl TR, Rowan KE, Sankaranarayanan K, Schafer DW, Stefanski LA, Ullrich RL, Jostes R. Beir VII: Health Risks from Exposure to Low Levels of Ionizing Radiation. Report in Brief Prepared by the National Research Council. National Academies Press: Washington, DC, 2001; available from:
  • 42
    Liss P, Persson PB, Hansell P, Lagerqvist B. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int 2006; 70:18111817.
  • 43
    Sabondjian E, Lewden B, Prato FS, Stodilka RZ. Gated cardiac SPECT/CT: slow CT or fast CT? J Nucl Med Meeting Abstr 2008 May; 49:64.